MUSCLE-INVASIVE BLADDER CANCER
Clinical trials for MUSCLE-INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new MUSCLE-INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for MUSCLE-INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to improve bladder cancer outcomes
Disease control OngoingThis study tests whether adding immunotherapy drugs (nivolumab with or without BMS-986205) to standard chemotherapy before and after bladder removal surgery helps people with muscle-invasive bladder cancer live longer without the cancer coming back. About 855 adults who are eligi…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 05:59 UTC
-
New hope for tough bladder cancers: personalized drug cocktails under study
Disease control OngoingThis study tests several different drug combinations in people with advanced bladder cancer that has gotten worse after earlier treatments. The goal is to find out which combinations are safe and might work best based on the specific genetic changes in each person's tumor. About …
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
Bladder cancer drug combo shows promise in major trial
Disease control OngoingThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy (gemcitabine and cisplatin) before surgery, followed by durvalumab alone after surgery, helps people with muscle-invasive bladder cancer. About 1,000 participants are involved. The goal is …
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 05:48 UTC
-
Bladder cancer drug shows promise in preventing recurrence after surgery
Disease control OngoingThis study tests whether the drug atezolizumab can help prevent bladder cancer from coming back after surgery to remove the bladder. It includes 761 people with high-risk muscle-invasive bladder cancer who had their bladder removed and still have signs of cancer DNA in their bloo…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New hope for bladder cancer patients who Can't take standard chemo
Disease control OngoingThis study tests two new drug combinations for people with muscle-invasive bladder cancer who cannot take the standard chemotherapy drug cisplatin. About 712 participants will receive either a combination of three drugs (durvalumab, tremelimumab, and enfortumab vedotin) or two dr…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 18, 2026 12:09 UTC